Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2005, Volume 29, Issue 2

The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.

Related Content:

AnalyticsFormulationManufacturingQuality SystemsGeneric DrugsDevelopmentPharmaceutical Technology-02-02-2005
Single-Use Technologies Reinforce Fluid-Handling Workflows (INTERPHEX 2024)
Improving ADC Manufacture Means Stricter Containment Requirements and Continuous Advancement of Analytics (INTERPHEX 2024)
CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions